Leadership & Pay · Oct 14, 2026Longeveron CMO Nataliya Agafonova steps down effective Oct. 14LGVNLongeveron Inc.Dr. Nataliya Agafonova informed management of her decision to step down as Chief Medical Officer, with the departure becoming effective on October 14, 2026. Longeveron Inc. operates in the biotechnology sector, focusing on cellular therapies.
